The FINANCIAL -- Bayer HealthCare AG and Onyx Pharmaceuticals, Inc. on September 30 announced results from a randomized, placebo-controlled Phase II trial sponsored by Northwestern University.

The FINANCIAL -- Bausch & Lomb, the global eye health company, on September 28 announced that several of its pharmaceuticals subsidiaries have been granted rights from CROMA Pharma GmbH to co-promote and sell bromfenac ophthalmic solution in Europe when it becomes available to the market.

The FINANCIAL -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced on September 29 the company’s action plan to provide methodologically robust research that will contribute to the scientific resolution of the debate over insulin safety, including insulin analogs and Lantus (insulin glargine).

The FINANCIAL -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced on September 28 that the U.S. District Court for the Southern District of New York has dismissed with prejudice the putative securities class action law suit previously brought against the Company.

The FINANCIAL -- Eli Lilly and Company (NYSE: LLY) received the Corporate Leadership Award from Lambda Legal at their annual benefit dinner on Friday in Indianapolis. Lilly was recognized for their efforts to further civil rights for the lesbian, gay, bisexual and transgender (LGBT) community.